Notably, DADS treatment significantly increased the formation of γ-H2AX and 53BP1 (two markers of the early DNA damage) foci in CRC cells (P<0.05, Figure 2A andFigure S2A). The gene discussed is H2AX; the disease is colorectal carcinoma.